Faruqi & Faruqi, LLP Announces Investigation Related to the Acquisition of ZymoGenetics, Inc. – ZGEN
08 Settembre 2010 - 10:43PM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of ZymoGenetics, Inc. (“ZymoGenetics” or the “Company”)
(NasdaqGM: ZGEN) for potential breaches of fiduciary duties in
connection with their conduct related to the sale of the Company to
Bristol-Myers Squibb Company (NYSE: BMY). The proposed transaction
offers ZymoGenetics shareholders to only receive $9.75 in cash for
each share they own.
Whether the ZymoGenetics’ Board of Directors breached their
fiduciary duties to ZymoGenetics’ stockholders by failing to
conduct an adequate and fair sales process to sell the Company
prior to agreeing to this proposed transaction, whether the
proposed transaction undervalues ZymoGenetics shares and by how
much this proposed transaction undervalues the Company to the
detriment of ZymoGenetics shareholders are the key focus of this
investigation.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, through all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in ZymoGenetics and wish to obtain
additional information, please visit us at
www.faruqilaw.com/zymogenetics or contact Juan E. Monteverde, Esq.
either via e-mail at jmonteverde@faruqilaw.com or by telephone at
(877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2010 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Grafico Azioni Generation Z ETF (NASDAQ:ZGEN)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Generation Z ETF (NASDAQ:ZGEN)
Storico
Da Nov 2023 a Nov 2024
Notizie in Tempo Reale relative a Generation Z ETF (NASDAQ): 0 articoli recenti
Più Faruqi & Faruqi, LLP Articoli Notizie